| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.58 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |